Thomas Bartrum, the former Executive Vice President and General Counsel of Privia Health Group, Inc. (NASDAQ:PRVA), has completed a sale of company shares on April 30, according to a recent filing. The transaction involved the sale of 2,252 shares of common stock at a price of $18.42 each, totaling over $41,481.
The sale was part of a mandatory process to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units. As noted in the filing, these kinds of sales are non-discretionary and are required under such circumstances.
Following the transaction, Bartrum continues to hold 103,862 shares of Privia Health Group, indicating a sustained stake in the company's future. The sale, while mandatory, reflects the ongoing financial movements of key individuals within the organization.
Privia Health Group, Inc., with its headquarters in Arlington, Virginia, operates within the health services industry, providing a variety of healthcare services. Investors often monitor the buying and selling activity of company insiders as an indicator of confidence in the firm's prospects and management.
As of the last report, Privia Health's shares are traded under the ticker symbol PRVA on the NASDAQ exchange. The company's business address is located at 950 N. Glebe Rd., Suite 700, Arlington, VA, 22203, the same address listed for Bartrum in the filing.
InvestingPro Insights
Privia Health Group, Inc. (NASDAQ:PRVA) has been navigating the dynamic healthcare services market with a notable financial footprint. According to recent data from InvestingPro, the company holds a market capitalization of $2.18 billion, showcasing its substantial presence in the industry. Despite a challenging environment, Privia Health's revenue has demonstrated resilience, with a growth of 22.19% over the last twelve months as of Q4 2023, a testament to its operational capabilities.
Investors considering Privia Health Group should note that the firm is trading at a high P/E ratio of 92.73. This could suggest investor optimism about future earnings potential, especially when paired with the InvestingPro Tip that the company's net income is expected to grow this year. Additionally, the company's gross profit margin stands at 9.74%, which could indicate room for improvement, aligning with the InvestingPro Tip that Privia Health suffers from weak gross profit margins.
For those looking to delve deeper into the company's financial health, Privia Health is currently trading near its 52-week low, which may present a potential entry point for value investors. To gain further insights and access to additional InvestingPro Tips, such as the company's cash position and earnings multiples, interested parties can explore the full suite of analytics available at https://www.investing.com/pro/PRVA. There are 11 additional tips listed in InvestingPro that could provide a more comprehensive understanding of Privia Health's financial outlook.
For a more informed investment decision, take advantage of the exclusive offer with the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.